IRRH
IRREGULARITY FROM IB EXAMINED BY MPU
11/08/2026
Voltar para busca
Dado oficial do USPTO
GOLD STANDARD DIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
11/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1
Data de depósito
13/11/2023
Data de registro
02/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/12/2025
Última transação
11/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IE
Examinador
THOMPSON, HEATHER
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "GOLD STANDARD DIAGNOSTICS" in navy blue to the left and slightly below a gold figure comprised of three interlocking incomplete polygons.
Titulares e representantes
Titulares
EUROFINS SCIENTIFIC (IRELAND) LIMITED
Representantes
JOSEPH SOFER IPSILON USA, LLP
Classificação técnica
Classes Nice
Classe 1
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for diagnostic use in industrynot for medical use; chemical preparations for scientific use; reagents for diagnostic chemical analyses for non-medical purposes; diagnostic preparations for scientific use and research; diagnostic preparations for industrial or laboratory useother than for medical or veterinary purposes; diagnostic chemical test kits for industrial and laboratory useother than for medical use ; diagnostic chemical test kits other than for medical use for scientific and research use; analysis and diagnostic test kits for scientific and research usereagents and buffers; analysis and diagnostic test kits for industrial and laboratory usereagents and buffers; PCR kitsdiagnostic chemical testing kits for environmental surfaces testsfor food testingfor laboratory or research useall other than for medical use; PCR kitsreagents and control samplesnot for use in medical or veterinary diagnosis; ELISA and other antibody-based kits not for medical useconsisting primarily of chemical reagents for diagnostic useother than for medical use; ELISA and other antibody-based kitstest bands and stripsmicrotiter platescoated test tubes and magnetic particles for the detection of chemical and biochemical and biological molecules or parts thereof for scientificlaboratoryindustrial use and not for medical diagnostic use; standard chemical analysis solutions for detection of chemical or biochemical molecules for scientificlaboratory and industrial use and not for medical diagnostic use; chemically modified magnetic beads for fixing chemical or biochemical compounds for the detection of chemical or biochemical compounds for scientificlaboratoryindustrial use and not for medical diagnostic use; reagent kits comprised of proteinspolypeptides and chemical reagents not for medical use.
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
IRFI
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
06/08/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/06/2026
FIMP
FINAL DISPOSITION PROCESSED
24/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/10/2025
PUBO
PUBLISHED FOR OPPOSITION
14/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2025
EXPT
EXPARTE APPEAL TERMINATED
16/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/09/2025
ALIE
ASSIGNED TO LIE
15/09/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/09/2025
EXPI
EX PARTE APPEAL-INSTITUTED
04/09/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/09/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/09/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/06/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/05/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/05/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/03/2025
GNFR
FINAL REFUSAL E-MAILED
04/03/2025
CNFR
FINAL REFUSAL WRITTEN
04/03/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
28/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/01/2025
DRRR
DIVISIONAL REQUEST RECEIVED
08/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/01/2025
RFNT
REFUSAL PROCESSED BY IB
28/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/07/2024
RFRR
REFUSAL PROCESSED BY MPU
10/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/06/2024
CNRT
NON-FINAL ACTION WRITTEN
20/06/2024
DOCK
ASSIGNED TO EXAMINER
19/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
23/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/01/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
21/12/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GOLD STANDARD DIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.